Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis

M Reid, YJP Agbassi, N Arinaminpathy, A Bercasio… - The Lancet, 2023 - thelancet.com
Although COVID-19 has undermined global progress, many African countries have
sustained declines in tuberculosis mortality rates. With excellent short-course preventive …

Tuberculosis prevention: current strategies and future directions

A Vasiliu, L Martinez, RK Gupta, Y Hamada… - Clinical Microbiology …, 2024 - Elsevier
Background An estimated one fourth of the world's population is infected with
Mycobacterium tuberculosis, and 5–10% of those infected develop tuberculosis in their …

Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in …

A Bhargava, M Bhargava, A Meher, GS Teja… - The Lancet Global …, 2023 - thelancet.com
Background Undernutrition is a common comorbidity of tuberculosis in countries with a high
tuberculosis burden, such as India. RATIONS is a field-based, cluster-randomised controlled …

Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies

TA Jhaveri, D Jhaveri, A Galivanche… - PLoS …, 2024 - journals.plos.org
Background India accounts for about one-quarter of people contracting tuberculosis (TB)
disease annually and nearly one-third of TB deaths globally. Many Indians do not navigate …

Immunopathology in human tuberculosis

TJ Scriba, M Maseeme, C Young, L Taylor… - Science …, 2024 - science.org
Mycobacterium tuberculosis (M. tb) is a bacterial pathogen that has evolved in humans, and
its interactions with the host are complex and best studied in humans. Myriad immune …

The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: a mathematical modelling study

NA Menzies, NA Swartwood, T Cohen… - The Lancet Public …, 2024 - thelancet.com
Background For settings with low tuberculosis incidence, disease elimination is a long-term
goal. We investigated pathways to tuberculosis pre-elimination (incidence< 1· 0 cases per …

Nutritionally acquired immunodeficiency must be addressed with the same urgency as HIV to end tuberculosis

MR Dauphinais, KG Koura, PB Narasimhan… - BMC Global and Public …, 2024 - Springer
Tuberculosis (TB) is the leading infectious killer worldwide, with 10.6 million cases and 1.6
million deaths in 2021 alone. One in 5 incident TB cases were attributable to malnutrition …

Need for operational simplicity and timely disbursal of benefits—a qualitative exploration of the implementation of a direct benefit transfer scheme for persons with …

M Mohan, JWV Thangaraj, S Pandey… - Infectious Diseases of …, 2024 - mednexus.org
Background Ni-kshay Poshan Yojana (NPY) is a direct benefit transfer scheme of the
Government of India introduced in 2018 to support the additional nutritional requirements of …

Nontuberculous mycobacterial pulmonary disease: patients, principles, and prospects

MVH Nguyen, MK Haas… - Clinical Infectious …, 2024 - academic.oup.com
Nontuberculous mycobacterial pulmonary disease (NTM-PD) is increasing in incidence
globally and challenging to manage. The 2020 multisociety treatment guideline and the …

Tuberculosis infection prevention and control

M Sarkar - Indian Journal of Tuberculosis, 2024 - Elsevier
Tuberculosis (TB) is the second leading infectious cause of death worldwide, only
surpassed by corona virus infection (COVID-19). It is mainly transmitted by the airborne …